This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cytokinetics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Christopher Evans: Inventor of NAMPT Modulators
Introduction
Christopher Evans is an inventor associated with Pacifica, California, and Cytokinetics, Inc. His patent work concerns NAMPT modulators, a class of compounds described for potential use in pharmaceutical compositions and methods.
Latest Patents
Evans is credited with 1 patent, titled “NAMPT Modulators.” The patent describes compounds of Formula (II), or pharmaceutically acceptable salts, with specified substituents and structural features. It also covers pharmaceutical compositions containing these compounds and methods for using them.
Career Highlights
Evans’s listed invention reflects work in pharmaceutical research and the development of compounds intended for therapeutic applications. His patent connects his inventive activity with Cytokinetics, Inc.
Collaborations
Antonio Romero is identified as Evans’s coworker. The available information does not specify their roles or describe a particular joint project.
Conclusion
Christopher Evans’s patent on NAMPT modulators documents his contribution to pharmaceutical innovation through compounds, compositions, and methods of use.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile